- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Prostate Adenocarcinoma in Denmark
Total 467 results
-
Herlev and Gentofte HospitalBristol-Myers SquibbRecruitingProstate Cancer Metastatic | Metastatic Castration-resistant Prostate Cancer | Castrate Resistant Prostate Cancer | Prostate Cancer Stage IVDenmark
-
Aarhus University HospitalKarolinska University Hospital; Karolinska Institutet; University of Aarhus; Central... and other collaboratorsUnknownProstate Cancer | Prostate Adenocarcinoma | Prostate NeoplasmDenmark
-
Rigshospitalet, DenmarkTerminated
-
Peter Busch ØstergrenRecruitingProstate Cancer MetastaticDenmark
-
WntResearch ABCompletedMetastatic Breast Cancer | Metastatic Prostate Cancer | Metastatic Colon CancerDenmark, United Kingdom
-
Herlev HospitalUnknownProstate Cancer Metastatic to BoneDenmark
-
Rigshospitalet, DenmarkTerminatedBone Metastases | Prostate Cancer MetastaticDenmark
-
Allarity TherapeuticsSmerud Medical Research International AS; Lantern Pharma Inc.Active, not recruitingIrofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)Metastatic Castration-Resistant Prostate Cancer PatientsDenmark
-
Orion Corporation, Orion PharmaCompletedAdvanced Breast Cancer | Metastatic Breast Cancer | Castration-resistant Prostate Cancer | Prostate Cancer MetastaticFinland, France, Denmark
-
WntResearch ABCompletedColorectal Cancer | Prostate Cancer | Metastatic Breast CancerDenmark
-
Aarhus University HospitalRigshospitalet, DenmarkTerminatedProstate Cancer | MetastasisDenmark
-
BayerCompletedBone Metastatic Castration-resistant Prostate CancerGermany, Netherlands, Denmark
-
Herlev HospitalCompletedProstate CancerDenmark
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaboratorsRecruitingRecurrent Prostate Cancer | Metastatic Prostate CancerFinland, Norway, Estonia, Denmark
-
Odense University HospitalUniversity of Southern DenmarkUnknown
-
Allarity TherapeuticsCompletedPhase 1: Advanced or Refractory Solid Tumours | Phase 2 Part: Metastatic Breast Cancer, Prostate Cancer and Skin CancerDenmark
-
RhoVac APSDantrials ApsCompleted
-
AstraZenecaScandinavian Prostate Cancer GroupCompletedNon-Metastatic Prostate CancerSweden, Finland, Norway, Denmark
-
CytoVac A/SCompletedHormone-refractory Prostate CancerDenmark
-
CytoVac A/SCompletedHormone-refractory Prostate CancerDenmark
-
IpsenTerminatedMetastatic Castrate Resistant Prostate CancerFrance, Spain, Poland, Belgium, Germany, Italy, Denmark, Lithuania, United Kingdom, Czechia, Hungary
-
Rigshospitalet, DenmarkCompletedCastration-resistant Prostate CancerDenmark
-
Copenhagen University Hospital at HerlevRecruitingProstate CancerDenmark
-
AmgenTerminatedMetastatic Castration-resistant Prostate CancerUnited States, Sweden, Spain, United Kingdom, Australia, Denmark
-
SanofiCompletedProstate Cancer MetastaticAustralia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Finland, Hungary, India, Ireland, Italy, Kazakhstan, Luxembourg, Malaysia, Mexico, Philippines, Poland, Portugal, Romania, Serbia, Singapo... and more
-
Bavarian NordicCompletedProstate Cancer MetastaticUnited States, Spain, Germany, Netherlands, Belgium, United Kingdom, Australia, Denmark, France, Canada, Israel, Russian Federation, Puerto Rico, Estonia, Poland, Iceland
-
Herlev HospitalEnrolling by invitationProstate CancerDenmark
-
Aarhus University HospitalActive, not recruitingBrain Metastases | Metastatic Rectal AdenocarcinomaDenmark
-
SOTIO a.s.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Spain, United Kingdom, Germany, Serbia, Portugal, Lithuania, Slovakia, Hungary, Netherlands, Croatia, France, Czechia, Poland, Austria, Belarus, Belgium, Bulgaria, Denmark, Italy, Latvia, Sweden
-
European Organisation for Research and Treatment...CompletedProstate Cancer | Metastatic CancerNetherlands, Denmark, Belgium, Poland, Switzerland, United Kingdom, Italy, Russian Federation, Portugal
-
Torben Brøchner PedersenCompleted
-
Herlev HospitalCompleted
-
Regional Hospital HolstebroCompleted
-
Rigshospitalet, DenmarkCompleted
-
Jørgen Bjerggaard JensenHospitalsenheden VestCompleted
-
Zealand University HospitalUniversity Hospital Schleswig-HolsteinUnknownHormone-refractory Prostate CancerDenmark, Germany
-
University of AarhusOdense University Hospital; Rigshospitalet, Denmark; Herlev Hospital; Vejle Hospital and other collaboratorsCompleted
-
Rigshospitalet, DenmarkCompleted
-
Herlev HospitalEli Lilly and Company; SanofiCompleted
-
Astellas Pharma Europe Ltd.Medivation, Inc.CompletedMetastatic Castration Resistant Prostate CancerCzechia, Netherlands, Denmark, Italy, Austria, Belgium, Bulgaria, France, Germany, Greece, Hungary, Ireland, Portugal, Slovenia, Spain, United Kingdom
-
Hinova Pharmaceuticals USA, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Prostate Cancer MetastaticGermany, Spain, Denmark, France, United Kingdom, Russian Federation, Poland, Australia, Italy, Netherlands, United States, Finland, Canada, Austria
-
Odense University HospitalNovo Nordisk A/S; AgeCare Academy of Geriatric Cancer ResearchCompleted
-
Scandion Oncology A/SAlcedis GmbHRecruitingMetastatic Pancreatic Adenocarcinoma | Locally Advanced Pancreatic Adenocarcinoma | Inoperable Disease | Localized Pancreatic AdenocarcinomaDenmark, Germany
-
Kristoffer RohrbergRecruitingMetastatic Cancer | Solid Tumor, AdultDenmark
-
Odense University HospitalCompleted
-
Danish Cancer SocietyUniversity of Copenhagen; TrygFonden, DenmarkUnknownProstate Cancer | Health Literacy | Computer LiteracyDenmark
-
Odense University HospitalCompleted
-
Odense University HospitalWithdrawn
-
Danish Cancer SocietyThe Capital Region Research Foundation for Health Research Denmark; Department... and other collaboratorsCompleted
-
Hospitalsenheden VestCompleted